Jochen Reiser
German nephrologist (born 1971) / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Jochen Reiser?
Summarize this article for a 10 year old
Jochen Reiser (born June 23, 1971, in Pforzheim, Germany) is a physician-scientist and a healthcare leader. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System,[1] which includes the oldest Medical School and Nursing School in the state of Texas. As Chief Executive Officer, he oversees the enterprise which includes multiple campuses, five health science colleges, the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Before UTMB, he served as the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center.[2] Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Dr. Reiser discovered the role of suPAR (soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for chronic kidney disease (CKD)[3] as well as for acute kidney injury (AKI).[4] suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics with potential benefit for a large patient population. His studies on suPAR molecule were featured in Science in 2018.[5] Dr. Reiser has been an advocate of science and innovation for two decades and was named as an inventor on multiple patents. He is co-founder of Cambridge, MA-based Walden Biosciences,[6] an ARCH Venture Partners joint-venture biopharmaceutical portfolio company dedicated to develop first-in-class therapeutics for kidney diseases.
Jochen Reiser | |
---|---|
Born | June 23, 1971 (1971-06-23) (age 52) Pforzheim, Germany |
Nationality | American/German |
Alma mater | Ruprecht-Karls-Universität Heidelberg |
Known for | Podocytes, Glomerular diseases, Chronic kidney disease (CKD), Focal segmental glomerulosclerosis (FSGS), Soluble urokinase plasminogen activator receptor (suPAR). |
Awards |
|
Scientific career | |
Fields | Nephrology |
Institutions | University of Texas Medical Branch |
Website | Office of the President - UTMB Health |